Abstract-A meal-estimation algorithm is developed based on an extended mathematical model of the glucose-insulin system. The proposed model describes the dynamics of glucose levels in blood and in subcutaneous layer, as well as the meal intake which is considered an unknown input of the system. This model seeks to represent in a more realistic manner, the pancreas malfunction in patients with Type 1 Diabetes Mellitus. Based on model, a non-linear high gain observer (NHGO) with a sliding mode is designed in order to estimate the unmeasured states and the external disturbances of the system. This scheme is useful to maintain frequent monitoring of glucose levels and any changes in its behaviour. The unknown input or disturbance is estimated through the sliding mode based only the estimation error. Data from a real patient is used to evaluate the effectiveness of the proposed estimation scheme.
I. INTRODUCTION
Type 1 diabetes is an autoimmune disease. Also known as Diabetes Mellitus, occurs when the body's immune system attacks the beta cells of the pancreas, which produce insulin. The reasons why the immune system attacks the beta cells are still unknown. This condition turns the type 1 diabetes into a disease extremely difficult or even impossible to prevent.
Patients suffering from type 1 diabetes are unable to produce insulin, which causes serious deviations of the glucose concentration level in the bloodstream. These significant and prolonged deviations from the normal level can lead to other severe pathologies as: adult blindness, endstage renal failure, retinopathy, neuropathy, and lower-limb amputations [1] .
In order to replace the pancreas function, patients with type 1 diabetes follow an insulin treatment coupled with a strict dietary control. For this, the insulin hormone is administered through discrete insulin injections or, used today to a lesser extent, through continuous subcutaneous infusion using an insulin pump. In the first case, discrete insulin injections are not considered therapeutically ideal, owing to that insulin doses are adjusted by the patient himself according to monitoring of blood glucose levels (at least four to six times per day), i.e., the regulation is made in open-loop. By nature, the regulation of blood glucose levels is a natural process in closed loop, for this reason the second case, i.e., continuous insulin infusions via (by means of) a programmable insulin pump, offers a potential better option to regulate the glucose level. An advantage of this procedure is the possibility to monitor and supply continually an insulin flow [1] .
In reality, to regulate the glucose level exists other problems associated to each individual patient. There are significant glucose level variability depending of several different events as: meals, mood, physical exercise, etc., which make difficult to calculate a suitable insulin dose for each patient. People with diabetes do not have normal insulin responses to adjust these variations, and may see their fasting glucose go up. All these events are unpredictabled and depend on each patient. In consequence, even today the fact to control the glucose level in diabetic patients is a big challenge to medical and scientific community [2] .
In order to develop an optimal solution, some mathematical algorithms via state observers have become an useful tool to estimate variables which cannot be directly measured. Also, several state observers have been designed in order to reconstruct the blood insulin concentration as is the case of [3] , [4] , who have developed non-linear observers based on models of the system. In [3] , an asymptotic state observer based on three different models of the system have being designed, while [4] presents a non-linear fractional-order unknown input observer strategy, which is used to reconstruct the state variables in spite of glucose rate disturbance representing the meals.
Likewise, on the literature we found observers making part of control schemes as [5] , who focus on designing a state feedback controller with an observer based on minimal model. In [6] the insulin level is estimated with a nonlinear observer coupled with a Linear Quadratic Gaussian (LQG) control, they together manage the insulin supply avoiding the hypoglycemic scenarios after meals. In another control scheme, a feedback law with a state observer based on a delay differential equation (DDE) model, is designed in order to estimate plasma glucose and insulin concentrations [7] . Finally, an Extended Kalman Filter (EKF) to estimate the glucose level and the time-varying parameters simultaneously, was presented by [8] .
This paper explores a new alternative approach via unknown input observers to estimate states and disturbances of the system. This work is based on results that incorporate a sliding mode term into a high-gain observer presented by [9] , [10] , in order to design a robust non-linear observer for a class of non-linear Lipschitz systems. For this, a non-linear high gain sliding-mode observer to estimate states and disturbances using only measurements of glucose concentration on subcutaneous layer is presented. The proposed observer uses the the sliding surface to estimate the unknown disturbance and, in addition, it is insensitive to parametric uncertainties, whose values are obtained via a reliable identification procedure.
The paper is organized as follows: in Section II some preliminaries and notation used on the present document are presented. In Section III the design of a non-linear high-gain observer (NHGO) with sliding mode will be developed for the glucose-insulin system. Section IV contains the proposed personalized model based on minimal model. In Section V numerical simulations based on real data from a diabetic patient are presented and discussed. Section VI provides the conclusions of present work.
II. PRELIMINARIES AND NOTATION
In this section, we give the system description and in order to define the observer structure, we also consider some assumptions which are described below. In like manner, a class of uniformly observable continuous-time non-linear systems is considered as follow:
where
T is the state vector, u(t) is the control input, B and P are known distribution vectors of inputs and disturbances, y(t) is the system output, f and h are non-linear functions depending of the states x(t). And finally, the unknown input vector is represented as d(t), which is considered a disturbance. In this case, the distribution vectors B and P have constant components, so they are naturally bounded into their arguments, which is necessary condition for the unknown input observer design. Assumption 1 characterizes a system that is uniformly observable for any bounded input. In like manner, uniform observability assumptions and Lipschitz assumptions are satisfied from the boundedness of states in the system. Based on this, the following definition presents additional necessary conditions for the design of the observer ensuring its convergence.
Definition 1. ( [11])
The system given by Eqs. (1-2) is called drift observable in Ω ∈ R n if the observability map can be presented as a non-linear transformation Φ(x(t)), which is a diffeomorphism in an open set that contains or coincides with Ω. So, Φ(x(t)) is a diffeomorphism ∀x(t) defined by:
where L f h(x(k)) represents the Lie derivative defined as:
In this case the drift-observability ensures that the Jacobian
∂Φ(x) ∂x
of the observability map is non-singular in Ω.
Assumption 3 ( [12]). The unknown input d(t) is observable from the output measurement, i.e., L p h(x) = 0, ∀(x).
In the next section, the design of a NHGO with slidingmode, with the objective to estimate the glucose and insulin concentrations, as well as the meal intake, will be presented.
III. NON-LINEAR HIGH-GAIN OBSERVER WITH SLIDING

MODE
Considering now the following non-linear system without disturbances, i.e., d(t) = 0, satisfying the Assumption 1:
A non-linear high gain observer having the following structure, can be designed based on the papers presented by [17] :
wherex(t) represents the estimated states and L represents the observer high gain, which is calculated as:
where S θ is the unique solution of the Lyapunov equation constant. Furthermore, the matrix S θ is symmetric positive definite for every θ > 0, which is calculated as:
A. Sliding-mode design
For a non-linear system given by Eqs. (1-2) , it is possible to design a robust non-linear observer with sliding mode [9] :
where the matrix Φ represents the observability map defined by Eq. (3). The unknown inputd(t) is estimated based on the design of a scalar-valued robust term as follow:
in this case, the accuracy of the unknown input estimation depends on δ. Considering the estimated residual error as:
the estimation of the unknown input is rewritten as:
where ρ is considered the sliding-mode gain. Based on Lemma 1 established in [9] , it is proved that the boundedness of the error e(t) depends of the parameter θ, i.e., θ is a design parameter, whose value can be chosen in order to reduce the bound of the estimation error. Hence, this bound can be used to calculate the sliding mode gain ρ (the convergence analysis is widely described in Theorem 1 and Lemma 2 given by [9] ).
The robust term presented by the sliding mode can be viewed as an element of tracking for the unknown input. In addition, an undesirable effect due to the abrupt change caused by the sign(·) function may occur. To avoid this, a saturation function should be included as follow:
where ε represents the boundary layer thickness, then, decreasing ε increases the accuracy in estimation. The fact to use the sat(·) function instead the sign(·) function, allows to establish the error dynamics inside the boundary layer rather than converging to zero in the sliding plane.
Thereafter it is possible to see that the unknown input estimation only depends on measurement error e(t) and, hence, can be performed on-line with state estimation. Then, the non-linear dynamic model proposed for the glucose-insulin system is presented in the next Section.
IV. AUGMENTED MINIMAL MODEL
Minimal model of glucose and insulin plasma levels in humans was proposed firstly by [13] . This model is the simplest valid model to describe the complex dynamic relationship between plasma glucose and insulin. Additionally, it is considered as a stimulus-response model of the extra-pancreatic tissues, which utilize glucose during frequently-sampled intravenous glucose tolerance (FSIGT) tests.
This model involves two physiological compartments: an insulin compartment and a glucose compartment (see Fig. 1 ). The top block shows the insulin kinetics where the plasma insulin (I(t)) enters a "remote insulin compartment" and it is active in accelerating glucose disappearance into the periphery and liver. In the insulin plasma block, an additional input corresponding to exogenous insulin (discrete injections or continuous flow supply) is considered. The down block, shows the block of the glucose kinetics where a function representing the meals has been taken into account. As a result of the added functions describing the patient conditions, the functionality of the glucose minimal model has been augmented. In order to obtain a more realistic representation of a person in a diabetic state, the original minimal model proposed by [13] , has been modified as follows:
Glucose subsystem:
In order to represent a patient in a diabetic state in a personalized way, in this work an augmented minimal model is proposed. With this intention, it is possible add a function representing the food intake, which allows to observe the effect of meal on the blood glucose concentration. This is done by adding a meal disturbance term D(t) into Eq. (13) as follow:
2016 ) where G(t) represents the blood glucose concentration (mg/dL), G b is the basal value of glucose concentration, X(t) is the effect of active insulin (min −1 ) in remote compartment, I(t) is the plasma insulin concentration (mU/L), p 1 is the glucose clearance rate independent of insulin (min −1 ), p 2 is the rate of clearance of active insulin (min −1 ) and p 3 increase in uptake ability caused by insulin ((μU/mL) −1 min −2 ). D(t) represents the glucose absorption rate, which can be calculated using the Rayleigh probability density function as follow:
with different parametric values for k depending on the size of the meal (i.e. carbohydrates amount), and for the constant b, which are listed in [14] .
Insulin subsystem:
Similarly in the insulin compartment, plasma insulin concentration is calculated. By using a function U I (t) representing the insulin entered the bloodstream, the exogenous insulin infusion is added, which replaces the function describing the insulin amount produced by pancreas, as follow:
where n is the fractional disappearance rate of insulin (mU/L) and U I (t) can be modeled as the rate of insulin absorption after a subcutaneous insulin discrete injection according to authors in [15] , as follows:
where t is the time elapsed from the injection (t s means t raised to the power s i ), T 50 is the time at which 50% of the insulin dose D I has been absorbed and s i is a parameter which defines the insulin absorption pattern depending of types of insulin (regular, intermediate, slow, etc.),. V I is the distribution volume of insulin in blood that should be estimated. The linear dependency of T 50 on dose is defined by:
where a i and b i are preparation-specific parameters and these values are given in [15] 
Glucose level in the subcutaneous layer:
In order to obtain a useful model according to the noninvasive monitoring techniques, the description of the glucose level in the subcutaneous layer is considered in this proposed model. Patients with diabetes type 1, usually test their blood glucose frequently (3 to 6 times per day), both to assess the effectiveness of their prior insulin dose and to help determine their next insulin dose.
For this reason, it is easier to monitor the glucose concentration through the subcutaneous layer measurements and not via intravenous. For this purpose, G sc (t) is introduced, which describes the glucose concentration in the subcutaneous layer via the following dynamic function:
where G sc (t) is the glucose concentration in the subcutaneous layer, the initial condition is defined as G sc (0) = (G(0) − 5)R utl . This equation represents a first-order delay (5 minutes) between the blood glucose concentration and the subcutaneous glucose concentration measurements. The R utl , is the rate of utilization, which is the difference between the two concentrations in steady state [16] .
Currently, one of the major problems concerning automatic control of glucose level is the proper estimation of this delay, but in our case, the Eq. 19 is a good approximation.
V. MAIN RESULTS
This study presents the design of a NHGO with slidingmode, for the purpose to estimate the glucose and insulin levels in plasma, as well as the food intake, using only the measurements of glucose on the subcutaneous layer. To accomplish this, the glucose-insulin model proposed in the Eqs. (13-19) must be presented in the form given by Eqs. (1-2), with the state vector
G(t) X(t) I(t) G sc (t)]
T .
The non-linear observer matrices are given as: 
and L is calculated from Eq. (7) with θ = 0.15 which is chosen small enough to reduce the bound of the estimation error, therefore the S θ matrix is calculated as follows: 
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The unknown parameters in this model: p 1 , p 2 , p 3 are estimated by applying weighted non-linear least squares method to experimental time-series data previously recollected from each individual patient. From these parameter values, two indices can be calculated: the insulin sensitivity index and the glucose effectiveness defined as S I = p 3 /p 2 and S G = p 1 respectively, which are used to reformulate the glucose-insulin dynamics and to complete the method for parameters estimation. For this, the Optimization Toolbox of Matlab is used.
A. Validation using data from a real patient
Database was obtained from a female diabetic patient, who remains in permanent treatment using an insulin pump. Glucose concentration measurements were collected via a EN LIT E MMT70008A subcutaneous sensor coupled with the MiniMed 530G insulin pump. Confirmatory finger-stick measurements were made, in order to adjust to insulin-therapy and to monitor the good sensor functioning.
Database corresponds to subcutaneous glucose concentration, exogenous insulin flow, amount of carbohydrates consumed and sampling time (in minutes). Based on this information and, using the proposed model described in Section IV, the unknown parameters of the model can be calculated for this patient in particular. Here, p 1 = 0.2134, p 2 = 0.0148 and p 3 = 3.237x10 −4 . For the observer design, based on value of the parameter θ = 0.15, whose value was chosen to reduce the bound of the estimation error, the sliding mode gain value ρ = 1.8 is calculated. Also, the estimation parameters δ = 8.5 and ε = 5 are fixed.
Several daily-scenarios were studied, but for space reasons only the results corresponding to data collected on two different days will be shown. In a first scenario the measurements were collected during 17h (since midnight until 5:00p.m.). During this time, the patient consumed two meals: at 8:05a.m. the breakfast and at 12:30p.m. the lunch, each one containing 120 g and 113 g of carbohydrates respectively. At the same time, the pump has constantly supplied an insulin variable flow between 0.6 and 2.03 U/h, which was only modified by postprandial insulin doses after each meal (according to patient needs).
In a second scenario the measurements were collected during 24h (since midnight). During this time, the patient consumed three meals and three snacks as follow: at 8:05a.m. the breakfast containing 83 g of carbohydrates, at 1:00p.m. the lunch with 120 g, at 6:30p.m. the dinner with 105 g and snacks at 9:40a.m., 4:30p.m. and 10:30p.m. each one containing 30 g, 23 g and 38 g of carbohydrates respectively. At the same time, the pump has constantly supplied an insulin variable flow between 0.325 and 1.88 U/h, which was modified by postprandial insulin doses in order to maintain a normal glucose level. In both cases, the disturbance was modelled as a sinusoidal term which represents the carbohydrates amount consumed during a meal ingestion. Figs. 4-5 present the glucose absorption rate (D(t)) calculated by the Eq. (15), and its estimation. To accomplish this, the disturbance is taken as an unknown input of the system and is estimated via a robust term presented by the sliding mode of the proposed observer.
One can see clearly the proposed observer guarantees a good convergence of the estimated states. It is possible also, to confirm that the proposed augmented minimal model is a useful tool used by the observer to reconstruct the known information and estimate the unmeasurable states. All estimations were made via the proposed non-linear high gain observer with sliding-mode, which is able to track the actual states. An important aspect that makes this work interesting is that the unknown input estimation only depends on measurement error, and the observer based-model allows improved estimation performance, i.e., the proposed observer guarantees an exponential convergence of the estimation error.
The performance of the NHGO with sliding-mode to estimate system states is proved. In this figures, glucose and insulin levels in plasma, as well as the insulin in remote compartment and the subcutaneous glucose level are accurately estimated in spite of disturbance presence. Therefore, it can be assumed that this observer is adequate to estimate the states (glucose and insulin concentrations), as well as the unknown input (meal intake) accurately.
VI. CONCLUSIONS
In this paper a non-linear high gain observer with sliding mode is presented. The proposed observer is based on augmented minimal model representing the glucose-insulin dynamic of the human body. This model is considered the simplest and it is found to be an useful tool to observer design. Functions representing delays on glucose subcutaneous measurements, unmeasurable meal disturbances and exogenous insulin type were considered to improve the model and make it customizable.
The robust high gain observer incorporates a sliding-mode term, which uses only the output estimation error to reconstruct the unknown input. The proposed observer is applied to estimate the glucose and insulin levels in plasma, as well as the meal disturbance. The simulation results demonstrate the effectiveness of the proposed approach by using adult real data. Control schemes based on observers will be the object of a future research.
